Рет қаралды 532
OBRoncology
Dr. Tannir, Professor of Medicine, The University of Texas MD Anderson Cancer Center, shares results of the 4 year follow up of Checkmate-214 investigating nivolumab + ipilimumab in 1st line RCC patients